approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 3/2025 Settlement Committee Order No. 40/2025 Dated 25/04/2025

) without the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535 SEC Act S.33 Settlement Committee Meeting No. 5/2025 Settlement Committee Order No. 90/2025 Dated

Limited’s shares offering in the form of general or to the public without approval from the SEC office. SEC Act S.300 in conjunction with 34 Settlement Committee Meeting No. 7/2025 Settlement Committee

VILLA MEDICA (PHUKET) CO.,LTD Between JUNE 2017 to December 2017, VILLA MEDICA (PHUKET) CO.,LTD offer to sell newly issued securities in the category of Debentures without approval from the SEC

Limited’s shares offering in the form of general or to the public without approval from the SEC office. SEC Act S.300 in conjunction with 34 Criminal Complaint Filed with an Inquiry Official Dated 15/10

., Ltd. offer for sale newly issued securities in the category of debentures without having obtained an approval from the SEC Office. SEC Act S.300 Criminal Complaint Filed with an Inquiry Official

Company Limited’s shares offering in the form of general or to the public without approval from the SEC office. SEC Act S.300 in conjunction with 34 Criminal Complaint Filed with an Inquiry Official

Kannithi Company Limited Kannithi Company Limited offered for sale newly issued securities in the category of debentures (Private Placement : PP) without approval from the SEC office which is in

Thanathip Consult Company Limited Thanathip Consult Company Limited offered for sale newly issued securities in the category of debentures (Private Placement : PP) without approval from the SEC

the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. This case is in the process of inquiry by the inquiry official SEC Act S.33 Criminal Complaint Filed